AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Origo

Related Party Transaction Mar 7, 2022

2208_rns_2022-03-07_554628b0-bc9a-4b2e-8d3f-9b5f089e2a0d.html

Related Party Transaction

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7068D

Origo Partners PLC

07 March 2022

07 March 2022

Origo Partners Plc

("Origo" or the "Company")

Asset Sale Update

Following the announcement made on 02 February 2022, Origo confirms that it has received the balance of the proceeds due from the sale of the Company's entire interest in Moly World.

Ends

For further information about Origo please visit www.origopartners.com or contact: 

Origo Partners plc

John Chapman

Chairman
55 Athol Street

Douglas

Isle of Man IM1 1LA
Nominated Adviser and Broker

Arden Partners plc

Richard Johnson
+44 (0)20 7614 5900

The information contained within this announcement is deemed by the Company to constitute inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 ("MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DISFZLFBLXLXBBF

Talk to a Data Expert

Have a question? We'll get back to you promptly.